Two distinctive antinociceptive systems in rats with pathological pain
Section snippets
Acknowledgements
This work was supported by the PHS grant DA08835. Δ9-tetrahydrocannabinol was kindly provided by Dr. Bill Martin at Medical College of Virginia.
References (18)
- et al.
Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain
Pain
(1988) - et al.
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Pain
(1988) - et al.
The analgesic effect of R(+)-Win 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain
Neurosci. Lett.
(1997) - et al.
Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia
Lancet
(1992) - et al.
Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain
Pain
(1995) - et al.
Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions
Pain
(1995) - et al.
The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive
Neurosci. Lett.
(1995) - et al.
Potentiation of delta-9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors
Eur. J. Pharmacol.
(1996) - et al.
SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice
Eur. J. Pharmacol.
(1997)
Cited by (99)
Central and peripheral anti-hyperalgesic effects of diosmin in a neuropathic pain model in rats
2018, Biomedicine and PharmacotherapyCannabidiol-Δ<sup>9</sup>-tetrahydrocannabinol interactions on acute pain and locomotor activity
2017, Drug and Alcohol DependenceSynergistic antinociceptive interaction between palmitoylethanolamide and tramadol in the mouse formalin test
2015, European Journal of PharmacologySkin β-endorphin mediates addiction to UV light
2014, CellCitation Excerpt :Here, naloxone was sufficient to induce conditioned place aversion in UV-irradiated mice, suggesting that chronic UV exposure imparts an opioid-like physical dependence of sufficient magnitude to guide proactive behavior choices. To test for the other principal feature of chronic opioid exposure, tolerance, after chronic UV treatment, we asked whether there is cross-tolerance between chronic UV exposure and morphine, altering the dose required to produce analgesia (Mao et al., 2000). After chronic UV exposure, mice required significantly higher doses of morphine than mock-treated controls to achieve comparable thermal analgesia in the hot-plate test, as reflected by a rightward shift in the dose-response curve and an increase in half-maximal effective concentration from 57 μg/kg in the mock-treated group to 270 μg/kg in the UV-exposed group (Figure 3C).
Synergistic anti-allodynic effects of nociceptin/orphanin FQ and cannabinoid systems in neuropathic mice
2011, Pharmacology Biochemistry and Behavior